Endometrial ablation: what counts?

Affiliations

¹ Dr. Sharp is an Associate Professor and Vice Chair for Clinical Affairs in the Department of Obstetrics and Gynecology at the University of Utah Health Sciences Center, Salt Lake City, Utah; e-mail: howard.sharp@hsc.utah.edu.

Editorial

Howard T Sharp. Obstet Gynecol. 2010 Oct.

. 2010 Oct;116(4):808-809.

doi: 10.1097/AOG.0b013e3181f47b15.

¹ Dr. Sharp is an Associate Professor and Vice Chair for Clinical Affairs in the Department of Obstetrics and Gynecology at the University of Utah Health Sciences Center, Salt Lake City, Utah; e-mail: howard.sharp@hsc.utah.edu.

No abstract available

Comment on

Bipolar radiofrequency endometrial ablation compared with hydrothermablation for dysfunctional uterine bleeding: a randomized controlled trial.
Penninx JPM, Willem Mol B, Engels R, van Rumste MME, Kleijn C, Koks CAM, Kruitwagen RFPM, Bongers MY. Penninx JPM, et al. Obstet Gynecol. 2010 Oct;116(4):819-826. doi: 10.1097/AOG.0b013e3181f2e3e3. Obstet Gynecol. 2010. PMID: 20859144 Clinical Trial.

1. Sharp HT. Assessment of new technology in the treatment of idiopathic menorrhagia and uterine leiomyomata. Obstet Gynecol 2006;108:990–1003.
1. Penninx JPM, Mol BW, Engels R, van Rumste MME, Kleijn C, Koks CAM, et al. Bipolar radiofrequency endometrial ablation compared with hydrothermablation for dysfunctional uterine bleeding: a randomized controlled trial. Obstet Gynecol 2010;116:819–26.
1. Corson SL. A multicenter evaluation of endometrial ablation by Hydro Thermablator and rollerball for treatment of menorrhagia. J Am Assoc Gynecol Laparosc 2001;8:359–67.
1. Cooper J, Gimpleson R, Laberge P, Galen D, Garza-Leal JG, Scott J, et al. A randomized, multicenter trial of safety and efficacy of the NovaSure system in the treatment of menorrhagia. J Am Assoc Gynecol Laparosc 2002;9:418–28.
1. Bongers MY, Bourdrez P, Mol BW, Heintz AP, Brölmann HA. Randomised controlled trial of bipolar radio-frequency endometrial ablation and balloon endometrial ablation. BJOG 2004;111:1095–102.